Related Experiment Videos

Oncogenic transformations in vitro produced by misonidazole

Cancer Clinical Trials
|January 1, 1980
PubMed

Insights

Electron affinic compounds, used as hypoxic cell radiosensitizers, can induce oncogenic transformations. SR 2508 showed significantly higher carcinogenicity than misonidazole and its analogs in cell line studies.

Area of Science:

  • * Cell biology and cancer research.
  • * Radiation oncology and drug development.

Background:

  • * Electron affinic compounds are investigated as hypoxic cell radiosensitizers.
  • * Understanding their oncogenic potential is crucial for clinical applications.

Purpose of the Study:

  • * To evaluate the oncogenic transformation induction by electron affinic compounds.
  • * To compare the carcinogenic potential of misonidazole and its analogs.

Main Methods:

  • * Utilized the C3H/10T 1/2 cell line in vitro.
  • * Exposed cells to various electron affinic compounds at specific concentrations for 3 days.
  • * Quantified the incidence of oncogenic transformations.

Main Results:

  • * Misonidazole and desmethylmisonidazole induced similar transformation frequencies.
  • * Ro-07-0741 doubled the transformation frequency compared to misonidazole.
  • * SR 2508 increased transformation frequency fivefold, indicating higher carcinogenicity.

Conclusions:

  • * The carcinogenic potential varies significantly among electron affinic radiosensitizers.
  • * SR 2508 exhibits a notably higher risk of oncogenic transformation.
  • * Carcinogenicity data is essential for selecting compounds for clinical trials.

Related Concept Videos